This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Cramer's 'Mad Money' Recap: Next Week's Game Plan (Final)

Advanced Diabetes Treatments

Rounding out Cramer's "Speculation Friday," features, Cramer dove into treating diabetes which affects 8% of all Americans at a cost of $116 billion a year. The diabetes epidemic is expected to grow to 25% of the U.S. population by 2024, thanks to the uncontrolled growth of obesity in our country.

Cramer said DexCom (DXCM - Get Report) and Insulet (PODD - Get Report), have the potential to change the way diabetes is treated over the next few years.

DexCom is leading the way in constant insulin monitoring devices. Unlike traditional finger pricks, which only monitor four times a day, DexCom's devices provides a constant stream of insulin levels. The company is expected to have $122 million in sales by 2012 and is growing at a 30% rate.

Insulet is leading the charge in insulin pumps, that deliver insulin to the body automatically, instead of relying on the patient to inject themselves. Insulet is waiting on FDA approval for it's latest unit, which is one-third smaller and costs a third less to manufacture.

However the most exciting prospects are when DexCom and Insulet's products are combined. DexCom's monitor alongside Insulet's pump provides essentially an artificial pancreas, which regulates its own insulin levels without patient intervention.

Cramer said the prospects for this new combined therapy could revolutionize the way diabetes is treated going forward, which is why these tow companies are the perfect speculation.

Lightning Round

Cramer was bullish on Starbucks (SBUX - Get Report), Schlumberger (SLB - Get Report), Limelight Networks (LLNW - Get Report) and Pitney Bowes (PBI).

He was bearish on Honda Motor (HMC), Agilent Technologies (A), Molycorp (MCP) and Skechers USA (SKX).

Closing Comments

In his "No Huddle Offense" segment, Cramer sounded off against his critics, who called him reckless for focusing on the hope of a Japanese rebuilding rather than the fear of a potential nuclear catastrophe.

Cramer said making money in the markets is all about buying the right stocks, at the right time. He said the bears have proven that there's no money to be made by panicking, but staying the course actually makes money. He said sometimes the situation can actually get better, which is why investors can't always listen to the naysayers.

--Written by Scott Rutt in Washington, D.C.

To contact the writer of this article, click here: Scott Rutt.

To follow the writer on Twitter, go to http://twitter.com/scottrutt.

To submit a news tip, send an email to: tips@thestreet.com.

To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.

Want more Cramer? Check out Jim's rules and commandments for investing from his latest book by clicking here.

For more of Cramer's insights during the Lightning Round, click here .

At the time of publication, Cramer was long Oracle.

Jim Cramer, host of the CNBC television program "Mad Money," is a Markets Commentator for TheStreet.com, Inc., and CNBC, and a director and co-founder of TheStreet.com. All opinions expressed by Mr. Cramer on "Mad Money" are his own and do not reflect the opinions of TheStreet.com or its affiliates, or CNBC, NBC UNIVERSAL or their parent company or affiliates. Mr. Cramer's opinions are based upon information he considers to be reliable, but neither TheStreet.com, nor CNBC, nor either of their affiliates and/or subsidiaries warrant its completeness or accuracy, and it should not be relied upon as such. Mr. Cramer's statements are based on his opinions at the time statements are made, and are subject to change without notice. No part of Mr. Cramer's compensation from CNBC or TheStreet.com is related to the specific opinions expressed by him on "Mad Money."

None of the information contained in "Mad Money" constitutes a recommendation by Mr. Cramer, TheStreet.com or CNBC that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the program. Mr. Cramer's past results are not necessarily indicative of future performance. Neither Mr. Cramer, nor TheStreet.com, nor CNBC guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the program. The strategy or investments discussed may fluctuate in price or value and you may get back less than you invested. Before acting on any information contained in the program, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.

Some of the stocks mentioned by Mr. Cramer on "Mad Money" are held in Mr. Cramer's Action Alerts PLUS Portfolio. When that is the case, appropriate disclosure is made on the program and in the "Mad Money" recap available on TheStreet.com. The Action Alerts PLUS Portfolio contains all of Mr. Cramer's personal investments in publicly-traded equity securities only, and does not include any mutual fund holdings or other institutionally managed assets, private equity investments, or his holdings in TheStreet.com, Inc. Since March 2005, the Action Alerts PLUS Portfolio has been held by a Trust, the realized profits from which have been pledged to charity. Mr. Cramer retains full investment discretion with respect to all securities contained in the Trust. Mr. Cramer is subject to certain trading restrictions, and must hold all securities in the Action Alerts PLUS Portfolio for at least one month, and is not permitted to buy or sell any security he has spoken about on television or on his radio program for five days following the broadcast.

3 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
DXCM $68.68 0.00%
LLNW $4.20 0.00%
PODD $28.12 0.00%
SBUX $51.48 0.00%
SLB $92.02 0.00%

Markets

DOW 18,232.02 -53.72 -0.29%
S&P 500 2,126.06 -4.76 -0.22%
NASDAQ 5,089.3620 -1.4320 -0.03%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs